These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction. Yinon Y; Ben Meir E; Berezowsky A; Weisz B; Schiff E; Mazaki-Tovi S; Lipitz S Am J Obstet Gynecol; 2014 Feb; 210(2):141.e1-7. PubMed ID: 24055584 [TBL] [Abstract][Full Text] [Related]
5. Angiogenic profile and smoking in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort. Jääskeläinen T; Suomalainen-König S; Hämäläinen E; Pulkki K; Romppanen J; Heinonen S; Laivuori H; Ann Med; 2017 Nov; 49(7):593-602. PubMed ID: 28537456 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia. Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758 [TBL] [Abstract][Full Text] [Related]
7. Maternal serum screening markers and nuchal translucency measurements in in vitro fertilization pregnancies: a systematic review. Lanes A; Huang T; Sprague AE; Leader A; Potter B; Walker M Fertil Steril; 2016 Nov; 106(6):1463-1469.e2. PubMed ID: 27530061 [TBL] [Abstract][Full Text] [Related]
8. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323 [TBL] [Abstract][Full Text] [Related]
9. Biochemical screening for aneuploidy in patients with donor oocyte pregnancies compared with autologous pregnancies. Gupta S; Fox NS; Rebarber A; Saltzman DH; Klauser CK; Roman AS J Matern Fetal Neonatal Med; 2014 Sep; 27(14):1418-21. PubMed ID: 24228730 [TBL] [Abstract][Full Text] [Related]
11. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population. Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492 [TBL] [Abstract][Full Text] [Related]
13. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies. Maymon R; Shulman A Hum Reprod; 2001 Apr; 16(4):691-5. PubMed ID: 11278220 [TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241 [TBL] [Abstract][Full Text] [Related]
15. Loss of placental thrombomodulin in oocyte donation pregnancies. Bos M; Baelde HJ; Bruijn JA; Bloemenkamp KW; van der Hoorn MP; Turner RJ Fertil Steril; 2017 Jan; 107(1):119-129.e5. PubMed ID: 27793368 [TBL] [Abstract][Full Text] [Related]
16. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. Korzeniewski SJ; Romero R; Chaiworapongsa T; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L Am J Obstet Gynecol; 2016 May; 214(5):629.e1-629.e17. PubMed ID: 26688491 [TBL] [Abstract][Full Text] [Related]
17. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia. Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883 [TBL] [Abstract][Full Text] [Related]
18. Serum immunoactive inhibin levels in early pregnancy after in vitro fertilization and embryo transfer. Yohkaichiya T; Polson DW; Hughes EG; MacLachlan V; Robertson DM; Healy DL; de Kretser DM Fertil Steril; 1993 May; 59(5):1081-9. PubMed ID: 8486178 [TBL] [Abstract][Full Text] [Related]
19. Impact of oocyte donation on perinatal outcome in twin pregnancies. Guilbaud L; Santulli P; Studer E; Gayet V; Goffinet F; Le Ray C Fertil Steril; 2017 Apr; 107(4):948-953.e1. PubMed ID: 28283263 [TBL] [Abstract][Full Text] [Related]
20. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia. Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]